Very-high-purity versus intermediate-purity factor VIII in human immunodeficiency virus-positive hemophiliacs: conclusions of a prospective 3-year study. Monoclate Study Group.
Seremetis
S V
SV
Department of Medicine, Mount Sinai School of Medicine, New York, NY 10029.
D000293:Adolescent; D000328:Adult; D015496:CD4-Positive T-Lymphocytes / Q000473:pathology; D002648:Child; D005169:Factor VIII / Q000009:adverse effects / Q000592:standards* / Q000627:therapeutic use; D006679:HIV Seropositivity / Q000150:complications*; D006467:Hemophilia A / Q000150:complications / Q000188:drug therapy* / Q000276:immunology; D006801:Humans; D007108:Immune Tolerance; D007958:Leukocyte Count; D008875:Middle Aged; D011446:Prospective Studies
D005169:Factor VIII